Today
+0.74%
5 Days
-3.33%
1 Month
-5.22%
6 Months
+6.85%
Year to Date
-14.47%
1 Year
-7.00%
• Macroeconomic headwinds and rising interest rates weighed on American Express shares. • Management plans increased spending on customer engagement, marketing, and technology. • Industry delinquency rates rose while analysts maintain an average price target of $375.93.
• Executive succession uncertainty and margin compression drove HDFC Bank ADR selling pressure. • Employee stock options and pending legal alerts fueled equity dilution and scrutiny concerns. • Technical breakdowns and institutional portfolio trimming contributed to the downward trading trajectory.
• American Express shares fell after missing quarterly earnings expectations. • Rising credit loss provisions indicate financial strain among premium cardholders. • Analysts lowered price targets amid cooling growth in travel and entertainment.
• American Express shares declined due to geopolitical tensions and surging global oil prices. • Travel sector instability negatively impacted American Express's revenue from premium lifestyle spending. • Institutional investors reduced stake sizes during the first half of the year.
• Piper Sandler initiated coverage on American Express with an Overweight rating and $396 price target. • Second-quarter billing growth remains strong, supported by resilient spending from an affluent consumer base. • American Express passed 2026 Dodd-Frank stress tests, maintaining a 2.5% stress capital buffer.
• American Express agreed to acquire TheFork for $700 million. • BofA reiterated "Buy" rating, citing strong second-quarter billing metrics. • Charge-offs were 2% in May 2026, with stable credit environment.


| Shareholders | Proportion |
|---|---|
| Berkshire Hathaway Inc. | 22.22% |
| Vanguard Capital Management, LLC | 4.84% |
| State Street Investment Management (US) | 4.32% |
| BlackRock Institutional Trust Company, N.A. | 3.77% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 37.14% |
| Holding Company | 22.26% |
| Investment Advisor/Hedge Fund | 19.72% |
| Research Firm | 3.20% |
Related Instruments